×
Efficacy and Safety of Mirtazapine in Major Depressive Disorder Patients After SSRI Treatment Failure: An Open-Label Trial PDF
$ 40.00
Efficacy and Safety of Mirtazapine in Major Depressive Disorder Patients After SSRI Treatment Failure: An Open-Label Trial PDF quantity
$ 40.00
×
Diagnostic Consistency of Major Depression With Psychosis Across 10 Years PDF
$ 40.00
Diagnostic Consistency of Major Depression With Psychosis Across 10 Years PDF quantity
$ 40.00
×
Prevalence, Correlates, and Treatment of Suicidal Behavior in US Military Veterans: Results From the 2019–2020 National Health and Resilience in Veterans Study PDF
$ 40.00
Prevalence, Correlates, and Treatment of Suicidal Behavior in US Military Veterans: Results From the 2019–2020 National Health and Resilience in Veterans Study PDF quantity
$ 40.00
×
Reboxetine, a Unique Selective NRI, Prevents Relapse and Recurrence in Long-Term Treatment of Major Depressive Disorder PDF
$ 40.00
Reboxetine, a Unique Selective NRI, Prevents Relapse and Recurrence in Long-Term Treatment of Major Depressive Disorder PDF quantity
$ 40.00
×
The Pharmacotherapy of Depressive Illness in Adolescents: An Open-Label Comparison of Fluoxetine With Imipramine-Treated Historical Controls PDF
$ 40.00
The Pharmacotherapy of Depressive Illness in Adolescents: An Open-Label Comparison of Fluoxetine With Imipramine-Treated Historical Controls PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart
